Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036261

EVP, Chief Accounting Officer gave up 12,132 shares (to pay taxes)

  • EVP, Chief Accounting Officer acquired 41,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Foster Wayne EVP, Chief Accounting Officer 2026-01-31 Option exercise +41,333 91,461 D
Foster Wayne EVP, Chief Accounting Officer 2026-01-31 Shares withheld for taxes −12,132 $4.24 $51,440 79,329 D
Derivatives
Foster Wayne EVP, Chief Accounting Officer 2026-01-31 Option exercise · Restricted Stock Units −33,333 0 D
Foster Wayne EVP, Chief Accounting Officer 2026-01-31 Option exercise · Restricted Stock Units −8,000 0 D
Foster Wayne EVP, Chief Accounting Officer 2026-01-31 Grant or award · Stock Option (Right to Buy) +108,000 108,000 D
Loading xslF345X05/ownership.xml…